NYP/Weill Cornell Medical Center — New York, New York

Public research footprint of NYP/Weill Cornell Medical Center, compiled from the ClinicalTrials.gov public registry.

198

Registered studies

129

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

Recently updated registry entries

NCT05047172 — Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular… (Active Not Recruiting)
NCT05976763 — Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for… (Recruiting)
NCT06439836 — Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at NYP/Weill Cornell Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.